all-in-one aav vector for epigenome editing shows efficient apoe downregulation in vivo
Published 1 year ago • 50 plays • Length 7:55Download video MP4
Download video MP3
Similar videos
-
5:02
developing apoe-targeted epigenome therapy for the treatment of alzheimer’s disease
-
1:03:57
r. snyder - recombinant aav vectors: persistence in vivo and clinical product release
-
1:23
adapted and the apoe gene
-
4:17
apoe gene program
-
3:08
aavantgarde bio’s dual-vector ush1b gene therapy moves into phase 1/2 clinical trial
-
6:41
stroke - apoe gene case study 3
-
1:18
episode 001: what is apoe
-
1:55
apolipoprotein e4 (apoe4) (transglutaminase substrate) bredesen&gundry
-
29:49
k. i. berns - evolution of aav vector for gene therapy
-
2:01
production of adeno-associated virus vectors in cell stacks
-
0:27
aplio i-series prism edition ibeam
-
2:13
bioniko | fundus 102 | basicsetup - advaned retina simulation
-
7:56
apolipoprotein e4 (apoe4) (transglutaminase substrate) by robert w mahley
-
1:14
the need for next-gen aav vectors
-
1:51
optimizing aav vectors with ai
-
7:00
1) adeno associated virus (aav) - an introduction
-
38:08
imi2 - call 5: webinar on topic 'apoe biology to validated alzheimer’s disease targets'
-
8:27
the story of apoe
-
1:54
apoe in late life depression